Barclays »

Aspire Biopharma Hldgs shares owned by Barclays

Quarter-by-quarter ownership of Aspire Biopharma Hldgs shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Aspire Biopharma Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Aspire Biopharma Hldgs held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aspire Biopharma Hldgs by Barclays

Quarter filed Position value Share count Share price at filing
2026-06-30 $5 1 5.00

More positions owned by Barclays

STATE STR SPDR S&ampP 500 ETF T Fund (SPY)
Ishares Tr Opt Call Option (EEM)
Microsoft Corp Opt Call Option (MSFT)
Invesco Qqq Tr Fund (QQQ)
Ishares Tr Fund (IWM)
Nvidia Corporation Opt Call Option (NVDA)
Micron Technology (MU)
Apple (AAPL)
Alphabet Inc Class A cs (GOOGL)
Amazon Opt Put Option (AMZN)
Vaneck Etf Trust Opt Put Option (SMH)
Tesla Motors (TSLA)
Advanced Micro Devices Opt Put Option (AMD)
Broadcom Opt Put Option (AVGO)
Ishares Tr Opt Call Option (HYG)

View all positions for Barclays

Top funds holding Aspire Biopharma Hldgs

Jane Street
Geode Capital Management
Vanguard Capital Management
Vanguard Fiduciary Trust
Crewe Advisors
Tower Research Capital
Toronto-Dominion Bank
Efficient Wealth Management
Crossingbridge Advisors
Mercer Global Advisors
SBI Securities
Barclays
UBS Group

View all funds holding Aspire Biopharma Hldgs